Published in Pathol Biol (Paris) on January 01, 1984
Transfer of a conditional ordering response through conditional equivalence classes. J Exp Anal Behav (1988) 8.35
Self-reinforcement effects: An artifact of social standard setting? J Appl Behav Anal (1985) 5.67
Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet (1996) 3.48
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin Pharmacol Ther (2010) 2.94
The transfer of respondent eliciting and extinction functions through stimulus equivalence classes. J Exp Anal Behav (1994) 2.55
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem (1998) 2.37
Creatine kinase-BB: a marker of liver sinusoidal damage in ischemia-reperfusion. Hepatology (1993) 2.23
Clinical operational tolerance after kidney transplantation. Am J Transplant (2006) 2.09
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients. Clin Pharmacol Ther (2009) 2.04
Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant (2010) 1.92
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant (2010) 1.86
Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant (2011) 1.77
De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant (2012) 1.74
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant (2009) 1.67
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant (2012) 1.60
Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology (1992) 1.60
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation. Am J Transplant (2009) 1.55
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology (1995) 1.54
In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation (1990) 1.53
Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53
Toxoplasma colitis in the acquired immunodeficiency syndrome. Am J Gastroenterol (1992) 1.46
Chronic hepatitis in kidney allograft recipients. Lancet (1990) 1.45
Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients. Transplantation (1995) 1.44
Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation (1998) 1.40
Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem (1999) 1.40
Choledocho-ureteral anastomosis in the rat. A new experimental model of long-term, total, internal bile diversion. J Hepatol (1993) 1.39
Sequential measurements of urinary albumin in recipients of renal allografts. Clin Chem (1991) 1.38
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. N Engl J Med (1989) 1.34
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant (2008) 1.31
Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol (1994) 1.26
Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am J Transplant (2008) 1.26
Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet (1993) 1.20
Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant (2009) 1.20
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant (2008) 1.17
Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin Chem (2000) 1.16
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes (1994) 1.13
Using bronchoscopy and biopsy to diagnose early inhalation injury. Macroscopic and histologic findings. Chest (1995) 1.10
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients. Transplantation (2001) 1.09
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Orthotopic aortic transplantation in mice: a new model of allograft arteriosclerosis. J Heart Lung Transplant (1999) 1.06
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot study. Am J Transplant (2007) 1.06
Cytochrome P-450 monooxygenase activities in human and rat liver microsomes. Eur J Biochem (1981) 1.04
Sirolimus may reduce fertility in male renal transplant recipients. Am J Transplant (2008) 1.04
Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? Am J Transplant (2010) 1.03
Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant (2006) 1.03
The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways. J Biol Chem (1995) 1.03
Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway. Toxicol Lett (1998) 1.03
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant (2009) 1.02
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant (2010) 1.01
[Quality specifications and allowable standards for validation of methods used in clinical biochemistry]. Ann Biol Clin (Paris) (1999) 1.01
Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). Transplantation (1999) 1.00
[The fibroblast]. Ann Pathol (1985) 0.99
Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids. Gastroenterology (1987) 0.99
Impact and evolution of peliosis hepatis in renal transplant recipients. Transplantation (1994) 0.98
Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology. Am J Transplant (2013) 0.98
Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur J Clin Microbiol Infect Dis (1995) 0.97
The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem (1996) 0.97
Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res (2001) 0.96
Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant (2010) 0.96
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies. Clin Chim Acta (1997) 0.95
Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes. Am J Transplant (2013) 0.94
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction. Kidney Int (2006) 0.94
HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant (2009) 0.93
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation (2000) 0.93
Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome. Am J Transplant (2009) 0.93
Age-related changes in the elastic tissue of the human thoracic aorta. Atherosclerosis (1990) 0.93
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. Am J Transplant (2015) 0.93
The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation (1996) 0.93
Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies. Am J Transplant (2014) 0.92
Fragmentation of penicillin catalysed by the exocellular DD-carboxypeptidase-transpeptidase of Streptomyces strain r61. Isotopic study of hydrogen fixation on carbon 6. FEBS Lett (1978) 0.91
Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology (1994) 0.91
Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet (1994) 0.91
Gambling pathology is associated with dampened cortisol response among men and women. Physiol Behav (2009) 0.91
Is cutaneous apoprotein B a better discriminator than serum lipoproteins for atherosclerosis? Atherosclerosis (1984) 0.91
Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis (2001) 0.90
European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect (2014) 0.90
Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation (1997) 0.89
Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation (1994) 0.89
Optimization of a model of full-thickness epidermal burns in the pig and immunohistochemical study of epidermodermal junction regeneration during burn healing. Dermatology (1992) 0.88
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials. Am J Transplant (2011) 0.88
Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study. Am J Transplant (2006) 0.88
[Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation]. Prog Urol (2008) 0.88
Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation. Clin Pharmacol Ther (2007) 0.88
Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J (1995) 0.87
Complete regression of a major hyperprolactinaemia after renal transplantation. Nephrol Dial Transplant (1999) 0.87
[Ultramicroscopic study of the idiopathic nephro-anemic syndrome]. Ann Anat Pathol (Paris) (1966) 0.87
Endothelin-1 secretion by human gallbladder epithelial cells in primary culture. Lab Invest (1993) 0.87
[Cartilaginous tissue and nalidixic acid]. C R Acad Sci Hebd Seances Acad Sci D (1978) 0.87
Metabolic stress promotes renal tubular inflammation by triggering the unfolded protein response. Cell Death Dis (2011) 0.87
Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J (1999) 0.87
Differential in situ expression of cytokines in renal allograft rejection. Transplantation (1991) 0.87
Fibroblast changes in cutaneous ageing. Virchows Arch A Pathol Anat Histopathol (1984) 0.86
A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells. FEBS Lett (1992) 0.86
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure. Am J Transplant (2014) 0.85
Liver disease from surreptitious administration of urethane. J Clin Gastroenterol (1993) 0.85
Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies. Transplant Proc (2007) 0.85